Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid

BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease that can lead to end-stage liver disease and cholangiocarcinoma. High-dose ursodeoxycholic acid (hd-UDCA, 28–30 mg/kg/day) was evaluated in a previous multicentre, randomised placebo-contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hochberg, Jessica T., Sohal, Aalam, Handa, Priya, Maliken, Bryan D., Kim, Take-Kyun, Wang, Kai, Gochanour, Eric, Li, Yu, Rose, J. Bart, Nelson, James E., Lindor, Keith D., LaRusso, Nicholas F., Kowdley, Kris V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172698/
https://www.ncbi.nlm.nih.gov/pubmed/37179785
http://dx.doi.org/10.1016/j.jhepr.2023.100729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172698/
https://www.ncbi.nlm.nih.gov/pubmed/37179785
http://dx.doi.org/10.1016/j.jhepr.2023.100729

Ejemplares similares